Elion Therapeutics
From a finished design to a working site.
A website for Elion Therapeutics, the Boston company developing next-generation antifungal therapies. Designed by Moxie. Built with EtchWP by The Media Council.
Visit website ↗The science sits beside the treatment.
Elion Therapeutics develops medicines for people whose cancer treatment, transplant care, or other immunosuppression leaves them vulnerable to severe fungal infection.
Today’s antifungals can be toxic, losing ground to resistance, and difficult to combine with the treatments patients already depend on. Turletricin (EL219), a next-generation polyene, is in Phase 2. A second candidate, EL777, is an inhaled antifungal approaching Phase 2. The site had to make that science legible, and stay current as studies, presentations, and news accumulate.
Moxie led the brand and the design. The Media Council built the website in Etch on WordPress, following that design through layout, typography, and responsive behavior.
The website
A credible public site for a clinical-stage company. Moxie’s design is intact, and Elion’s team has a WordPress site they can update as the science moves.
Visit website ↗Start with what needs to change.
We’ll help define the project, set the priorities, and find the right path forward.
Start a project